Marek Ciszewski | Investor Relations |
Denny Lanfear | Chief Executive Officer |
Theresa Lavallee | Chief Development Officer |
Rosh Dias | Chief Medical Officer |
Paul Reider | Chief Commercial Officer |
McDavid Stilwell | Chief Financial Officer |
Robyn Karnauskas | Truist Securities |
Salim Syed | Mizuho |
Mike Nedelcovych | TD Cowen |
Douglas Tsao | H.C. Wainwright |
Ash Verma | UBS |
Chris Schott | JPM |
Good day and thank you for standing by. Welcome to the Coherus Biosciences Q1 2023 Earnings Call. [Operator Instructions] Please be advised that today’s conference is being recorded. I would now like to hand the conference over to your first speaker, Marek Ciszewski of Investor Relations for Coherus BioSciences. Please go ahead.